Document:

Document

Exhibit 4.18

Summary of Free Share (AGA) Plan

Free shares, or AGA (actions gratuites), may be granted by our executive board to our employees, employees of our subsidiaries and members of our executive board. 

Administration. Pursuant to delegations granted at our general meeting of the shareholders, our executive board, upon recommendation of the compensation committee and with the approval of the supervisory board, determines recipients, dates of grant, the number of free shares to be granted and the terms and conditions of the free shares, including the length of their vesting period and, as the case may be, lock-up period within the limit determined by the shareholders.

Grant. Free shares are shares of Nanobiotix S.A. (the “Company”) that are granted for free to any individual employed by us or by any affiliated company under the terms and conditions of an employment contract. Free shares may also be granted to members of our executive board. However, no free shares may be granted to a beneficiary holding more than 10% of our share capital or to a beneficiary who would hold more than 10% of our share capital as a result of such grant. 

Vesting Period. The free shares granted under our free share plan will be definitively vested after a vesting period (period starting on the date of grant during which the beneficiary holds a right to acquire shares for free, but does not currently hold any shares) as set by our executive board. At the end of the vesting period, the beneficiary will be the owner of the shares. However, during the lock-up period (period starting at the end of the vesting period when the shares are definitively acquired and issued), as set by our executive board, if any, the shares may not be sold, transferred or pledged. The sum of the duration of the vesting and lock-up periods must be at least two years, in accordance with the provisions of Article L. 225-197-1 of the French Commercial Code.

Free shares we grant to French tax residents vest after a vesting period of a minimum of two (2) years and are subject to a lock-up period of at least one (1) further year. Free shares we grant to foreign tax residents vest after a vesting period of a minimum of three (3) years and are not subject to any lock-up period.

Underlying shares. Our AGA are new ordinary shares of our Company that are issued upon vesting of the AGA. Until they are vested, the number of AGA to which each beneficiary has right can be adjusted, upwards or downwards, as a result of certain corporate transactions, such as rights issues.

Standard terms. Unless otherwise decided by our supervisory and executive boards, our AGA will be definitively issued following a vesting period at the end of which the beneficiary must be effectively present in our Company or its consolidated subsidiaries (subject to exceptions) and, as the case may be, subject to the completion of performance conditions that are assessed by our executive board. Failing such continued service, the beneficiary definitively and irrevocably loses his or her right to acquire the relevant AGA.

Unless otherwise decided by our supervisory and executive boards, in the event of disability or death of a beneficiary before the end of the acquisition period, the relevant AGA shall be definitely acquired at, respectively, the date of disability or the date of the request of allocation made by his or her beneficiary in the framework of the inheritance, provided that such request is made within six months from the date of death.

Change in control. In the event of a merger into another corporation or of the sale by one or several shareholders, acting alone or in concert, of our Company to one or several third parties of a number of shares resulting in a change of control (a ‘‘Liquidity Event’’), unless otherwise decided by the executive and supervisory board, all of the free shares shall be completely and definitely acquired as follows: 

•For French tax residents, (i) if the Liquidity Event occurs before or on the first anniversary date of the grant and (ii) if the change of control occurs after the first anniversary of grant, on the date of completion of the Liquidity Event, it being specified that, in both cases, the relevant free shares will then be subject to a holding period until the second anniversary of the grant.

•For foreign tax residents, if the Liquidity Event occurs before the second anniversary of the grant, on the first anniversary of the grant, it being specified that, the relevant free shares will then be subject to a year-long holding period as from their date of acquisitionEX-10.1

 Exhibit 10.1 

April 2, 2021 
 Mr. Jeffrey York 

[*****] 
 [*****] 

Re: Amendment of Executive Employment Agreement and PSU Award 

Dear Mr. York: 
 This letter (this
“Agreement”) sets out the terms of your continuing relationship with Paycom Software, Inc. (the “Company”) and amends two agreements: first, that certain Amended and Restated Executive Employment
Agreement dated January 1, 2014 and amended and restated on March 9, 2020 (the “Existing Agreement”), and second, that certain Restricted Stock Unit Award Agreement – Performance-Based Vesting, between the
Company and you, dated February 10, 2021 (the “2021 PSU Award Agreement”), pursuant to which you were granted 20,790 Target Units, with a maximum of 51,975 Awarded Units (as such terms are defined in the 2021 PSU Award
Agreement) (the “2021 PSU Award”). Nothing herein affects any other equity award between you and the Company, including but not limited to (i) that certain Restricted Stock Award Agreement dated January 26, 2018,
between the Company and you, (ii) that certain Restricted Stock Award Agreement dated January 17, 2019, between the Company and you, or (iii) that certain Restricted Stock Award Agreement dated January 30, 2020, between the
Company and you. 
 You hereby resign from your role as Chief Sales Officer of the Company and accept the role of “Leadership
Strategist” for the Company, an at-will position, in each case effective as of April 2, 2021. Your duties in your new role are to provide leadership and strategic advice to the management team and
sales force and to perform any other duties as may be reasonably designated from time to time by the Chief Executive Officer. You acknowledge and agree that in your new role, you are no longer an executive officer of the Company. 

This Agreement amends the Existing Agreement as follows: 
  

	 	1.	 All references to “Executive” are hereby replaced with “Employee.” 

 

	 	2.	 Recital Number 5 is amended and restated in its entirety as follows: 

“WHEREAS, subject to the terms and conditions hereinafter set forth, the Company therefore wishes to employ Employee in the role of
Leadership Strategist, and Employee wishes to accept such employment;” 

	 	3.	 Section 2 is amended and restated in its entirety as follows: 

“Term. This Agreement shall commence on January 1, 2014 and shall continue until three (3) years following the
consummation of the initial Public Offering (which was on April 21, 2014), subject to earlier termination as herein provided (“Initial Term”). The Agreement has been renewed on April 22, 2017, April 22, 2018,
April 22, 2019 and December 31, 2020, and will automatically renew, subject to earlier termination as herein provided, for successive one (1) year periods (the “Additional Terms”) on January 1st of each year. The Initial Term and any Additional Term(s) shall be referred to collectively as the “Term.” The Company or Employee, upon 30 days’ written notice to the other
party, may end the Term at any time, for any reason or no reason (the date of such termination or the last day of the Term is the “Termination Date”).” 
  

	 	4.	 Section 3.1 is amended to replace all references therein to “Chief Sales Officer” with
“Leadership Strategist.” 

  

	 	5.	 Section 4.2 (including all cross-references thereto) is deleted, and Section 4.2 is replaced with
“Intentionally Omitted”. 

  

	 	6.	 Section 4.5 is amended and restated in its entirety as follows: 

“Other Benefits. Employee shall be entitled to participate in or receive benefits under any plan or arrangement made
available from time to time by the Company to its employees generally (including any health, dental, vision, disability, life insurance, 401k, or other retirement programs). Any such plan or arrangement shall be revocable and subject to termination
or amendment at any time only in accordance with the terms and conditions of such plans or arrangements, without recourse by Employee.” 
  

	 	7.	 Section 5 (including all cross-references thereto) is deleted, and Section 5 is replaced with
“Intentionally Omitted”. 

 Further, with respect to the 2021 PSU Award, you agree that as consideration of your
continued employment in a non-executive role with the Company, you voluntarily and knowingly agree to forfeit and relinquish the entire 2021 PSU Award. You acknowledge and understand that, on and after the
date of this Agreement, the 2021 PSU Award will be cancelled, terminated, and of no further force or effect, and neither you nor the Company will have any further rights or obligations with respect to the 2021 PSU Award or with respect to any shares
of common stock of the Company that could have been issued thereunder. You also acknowledge and agree that you will forfeit and waive any right to receive a bonus under the Annual Incentive Plan for the 2021 performance period and any future
performance period. 
 Finally, as of the date of this Agreement, you (for yourself and your successors and assigns) unconditionally and
irrevocably release and discharge the Company and its successors, assigns, parents, divisions, subsidiaries, and affiliates, and its present and former officers, directors, 

 
employees, and agents (collectively, the “Released Parties”) from any and all claims, counterclaims, set-offs, debts, demands,
choses in action, obligations, remedies, suits, damages, and liabilities in connection with (i) any rights to acquire securities of the Company pursuant to the 2021 PSU Award and the shares of common stock of the Company issuable thereunder,
(ii) your acceptance of your new role under this agreement and the discontinuation of your prior role, (iii) the Annual Incentive Plan, and your waiver of any bonus thereunder for the 2021 performance period and any future performance
period, and (iv) this Agreement (collectively, the “Released Claims”), whether now known or unknown, arising from common law, statute or in equity, which you or your successors or assigns ever had, have, or in the future
may claim to have against the Released Parties and which may have arisen at any time on or prior to the date of this Agreement. You agree never to commence or aid any action or proceeding against the Released Parties based on any of the Released
Claims. Notwithstanding the foregoing, this release shall not apply to any of the Company’s obligations under this Agreement. 
 By
signing below, you agree that you have been provided an opportunity of at least twenty-one days to review this Agreement (though you may sign the Agreement sooner), to consult counsel of your choosing
regarding this Agreement, and that you are knowingly and voluntarily signing this Agreement. 
 [Remainder of Page Intentionally Left
Blank 
 Signature Page Follows] 

 
			
	Kind Regards,
	
	PAYCOM SOFTWARE, INC.
		
		 	/s/ Frederick C. Peters II
		 	By: Frederick C. Peters II
		 	 Title: Lead Director of the Board of Directors,

on behalf of the Board of Directors

  

	
	ACCEPTED AND AGREED:
	
	 /s/ Jeffrey York

	Jeffrey York
	
	 April 2, 2021

	Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}]]